Colorado biotech shares soars after patent issued in Europe

Shares in Arca Biopharma Inc. were soaring in early Thursday trading after the biotech reported that one of its treatments for cardiovascular disease has been issued a patent in Europe. The Westminster biotech reported that the European patent was validated in: Denmark, France, Germany, Ireland, Italy, Netherlands, Spain, Sweden, Switzerland and the United Kingdom. Shares in Arca Biopharma (Nasdaq: ABIO) were up more than 30 percent in early Thursday trading, rising 37 cents to $1.55. The company…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news